UPDATE 3-Evolus investors frown as FDA declines to approve Botox rival
May 16, 2018 at 14:27 PM EDT
* Deficiencies not related to clinical or non-clinical matters
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|